Genmab Announces FDA Grants Priority Review for Daratumumab for Double Refractory Multiple Myeloma
September 04, 2015 at 14:28 PM EDT
Genmab A/S (OTC: GNMSF) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the Biologics ...
